RUNX1::RUNX1T1 is thought to initiate AML through its function as a transcriptional repressor, recruiting repression machinery to genomic CBF binding sites, downregulating CBF target genes (33–37). The gene discussed is CEBPZ; the disease is acute myeloid leukemia.